Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
66 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01532102 | Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts | completed | Phase 1 / Phase 2 | 24 | Anaconda PharmaINDUSTRY | 2 | May 30, 2018 | clinicaltrials |
| NCT01512199 | Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) | terminated | Phase 1 / Phase 2 | 29 | Daiichi SankyoINDUSTRY | 2 | Oct 18, 2017 | clinicaltrials |
| NCT00930514 |
| A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma |
| completed |
| Phase 1 |
| 281 |
| Hoffmann-La RocheINDUSTRY |
| 22 |
| Nov 2, 2016 |
| clinicaltrials |
| NCT00594984 | Phase I/II Combination With Irinotecan- Erbitux | completed | Phase 1 / Phase 2 | 38 | Bristol-Myers SquibbINDUSTRY | 7 | Nov 4, 2015 | clinicaltrials |
| NCT01598454 | Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides | completed | Phase 1 | 15 | Laboratorio Elea Phoenix S.A.INDUSTRY | 1 | Jul 29, 2015 | clinicaltrials |
| NCT00346255 | BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma(IMGN901) | completed | Phase 1 | 37 | ImmunoGen, Inc.INDUSTRY | 2 | Apr 23, 2013 | clinicaltrials |
| NCT00432562 | A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. | completed | Phase 1 | 31 | Mast Therapeutics, Inc.INDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00381654 | Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies | terminated | Phase 1 | 27 | AVEO Pharmaceuticals, Inc.INDUSTRY | 2 | Oct 4, 2011 | clinicaltrials |
| NCT00630110 | Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 172 | Nereus Pharmaceuticals, Inc.INDUSTRY | 6 | Aug 16, 2011 | clinicaltrials |
| NCT00489359 | Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | 86 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 16, 2011 | clinicaltrials |
| NCT00320515 | Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 89 | Eli Lilly and CompanyINDUSTRY | 4 | Sep 28, 2009 | clinicaltrials |
| NCT00664170 | A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer | completed | Phase 1 | 39 | Mast Therapeutics, Inc.INDUSTRY | 3 | May 28, 2009 | clinicaltrials |
| NCT00460876 | Phase I Trial of Periocular Topotecan in Retinoblastoma | completed | Phase 1 | 5 | Hospital JP GarrahanOTHER_GOV | 1 | May 2, 2008 | clinicaltrials |
| NCT00515983 | Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells | completed | Phase 1 | 16 | José Mordoh, M.D., Ph.D.OTHER | 1 | Aug 14, 2007 | clinicaltrials |
| NCT00160836 | Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter | unknown | Phase 1 | 68 | University Hospital, GenevaOTHER | 1 | Apr 19, 2007 | clinicaltrials |
| NCT00097383 | Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 5 | Jul 19, 2006 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials